Anti-Inflammatory Drugs Market Size | 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. The Global Anti-Inflammatory Drugs market expected to rise at 9.3% CAGR and reach 191.42 billion valuations by 2028. Anti-Inflammatory Drugs Industry is segmented By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis), Respiratory Diseases), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027
Get Sample Report On Global Anti-Inflammatory Drugs Market:
Global Anti-Inflammatory Drugs Market Highlights:
The Anti-Inflammatory Drugs Market report offers an in-depth analysis of the Anti-Inflammatory Drugs industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Anti-Inflammatory Drugs market concentration, and maturity analysis is elaborated in this report.
The global anti-inflammatory market size is expected to reach USD 191.42 billion by 2027 on account of increasing investments on the development of biologics for treating autoimmune inflammatory diseases. Anti-inflammatory drugs help to reduce inflammation in the body and treat health conditions such as arthritis, asthma, rheumatoid arthritis, sinusitis, and others. A recently published report by Fortune Business Insights offers a comprehensive overview of the market and its prime growth trajectories. As per the report titled, “Anti-Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis, and Others), Respiratory Diseases, and Others), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027,” the value of the market was USD 93.88 billion in 2019 and is expected to rise at a CAGR of 9.3% between 2020 to 2027.
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
The report offers a comprehensive overview of the market and its growth parameters such as drivers, restraints, challenges, and upcoming opportunities. The report also offers interesting insights into the market, current trends, and significant industry developments. It also throws light on key players functioning in the market and the key strategies adopted by them to compete for the top position. The report further discusses the segmentation of the market based on factors such as drug-class, application, route of administration, distribution channel, and geography, and lists the names of the leading segment with attributed factors. The report offers an overall qualitative and quantitative analysis of the market and is available for sale on the company website.
The increasing prevalence of inflammatory diseases namely ulcerative colitis, inflammatory bowel, psoriasis, and rheumatoid arthritis, and others are the major anti-inflammatory drugs market growth driver. As per the Centers for Disease Control and Prevention, an estimate of 78 million people in the U.S. will be diagnosed with arthritis by the end of 2040. Apart from this, the increasing uptake of corticosteroids for treating chronic obstructive pulmonary diseases (COPD) and asthma, coupled with the increasing prevalence of atopic dermatitis are likely to aid in the expansion of the market in the long run.
On the contrary, the side effects of using non-steroids anti-inflammatory drugs or NSAIDs such as dizziness, allergic reactions, stomach pain, stomach ulcers, and others may pose a major threat to the market in the coming years. This, coupled with the risk of gastrointestinal bleeding and other complications may hinder the market in the coming years.
Many players are operating in the global market for anti-inflammatory drugs out of which Johnson & Johnson and AbbVie are holding the dominant shares. The rise in the number of Humira, a multiple indications monoclonal antibody for multiple indications such as ulcerative colitis, psoriasis arthritis, and rheumatoid arthritis, among others is responsible for AbbVie earning major revenues in the market. As per research analysts at Fortune Business Insights, this company generated a revenue of USD 19.2 billion solely from Humira sales worldwide. Similarly, the sale of Simponi, Sterala, and Remicade by Johnson & Johnson has helped this company enjoy the dominant position in the market. Besides this, other players are engaging in merger and acquisition, contracts and agreements, joint ventures, and other collaborative efforts to gain a competitive edge in the market.
It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for Anti-Inflammatory Drugs market to figure out and study the market’s needs, market size, and competition.
Regional Analysis:
Geographically, the market is dominated by North America with the rising demand for anti-inflammatory biologics, and government support for their launches. In 2019, North America earned a revenue of USD 41.39 billion, attributed to the massive investments in research and development that further expanded the regional market. The market in Europe, on the other hand, is likely to witness significant growth on account of active government support for launching biosimilars, and favorable health reimbursement policies. Moreover, the market in Asia Pacific will rise at a rapid speed on account of improving healthcare infrastructure and facilities, coupled with the increasing geriatric population, and rising preference for generic corticosteroids and NSAIDs. Furthermore, the Middle East and Latin American markets will gain momentum on account of the growing incidences of rheumatoid arthritis and improving healthcare infrastructure in the respective regions.
This report focuses on Anti-Inflammatory Drugs Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
Anti-Inflammatory Drugs Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Competitive Analysis And Industry News:
Major companies in the global Anti-Inflammatory Drugs Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends & drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the Anti-Inflammatory Drugs Industry.
Key questions answered in the report:
- What will the market growth rate of Anti-Inflammatory Drugs Market in 2026?
- What are the key factors driving the global Anti-Inflammatory Drugs Market?
- Who are the key manufacturers in Anti-Inflammatory Drugs Market space?
- What are the market opportunities, market risk and market overview of the Anti-Inflammatory Drugs Global market?
- What are sales, revenue, and price analysis of top manufacturers of Anti-Inflammatory Drugs Global market?
- What are sales, revenue, and price analysis by types and applications of Anti-Inflammatory Drugs Market?
- What are sales, revenue, and price analysis by regions of Anti-Inflammatory Drugs Market?
Table Of Content:
1 Market Overview
1.1 Anti-Inflammatory Drugs Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2020-2026)
1.4.1.2 Canada Market States and Outlook (2020-2026)
1.4.1.3 Mexico Market States and Outlook (2020-2026)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2020-2026)
1.4.2.2 France Market States and Outlook (2020-2026)
1.4.2.3 UK Market States and Outlook (2020-2026)
1.4.2.4 Russia Market States and Outlook (2020-2026)
1.4.2.5 Italy Market States and Outlook (2020-2026)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2020-2026)
1.4.3.2 Japan Market States and Outlook (2020-2026)
1.4.3.3 Korea Market States and Outlook (2020-2026)
1.4.3.4 India Market States and Outlook (2020-2026)
1.4.3.5 Southeast Asia Market States and Outlook (2020-2026)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2020-2026)
1.4.4.2 Egypt Market States and Outlook (2020-2026)
1.4.4.3 Saudi Arabia Market States and Outlook (2020-2026)
1.4.4.4 South Africa Market States and Outlook (2020-2026)
1.4.4.5 Turkey Market States and Outlook (2020-2026)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Anti-Inflammatory Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anti-Inflammatory Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Anti-Inflammatory Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Inflammatory Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Anti-Inflammatory Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Anti-Inflammatory Drugs Market Analysis by Regions
4.1 Global Anti-Inflammatory Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Inflammatory Drugs Sales and Market Share by Regions (2020-2028)
4.1.2 Global Anti-Inflammatory Drugs Revenue and Market Share by Regions (2020-2028)
4.2 North America Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
4.3 Europe Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
4.4 Asia-Pacific Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
4.5 South America Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
4.6 Middle East and Africa Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
5 North America Anti-Inflammatory Drugs by Country
5.1 North America Anti-Inflammatory Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anti-Inflammatory Drugs Sales and Market Share by Country (2020-2028)
5.1.2 North America Anti-Inflammatory Drugs Revenue and Market Share by Country (2020-2028)
5.2 United States Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
5.3 Canada Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
5.4 Mexico Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
8 South America Anti-Inflammatory Drugs by Country
8.1 South America Anti-Inflammatory Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anti-Inflammatory Drugs Sales and Market Share by Country (2020-2028)
8.1.2 South America Anti-Inflammatory Drugs Revenue and Market Share by Country (2020-2028)
8.2 Brazil Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
8.3 Argentina Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
8.4 Colombia Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
9 Middle East and Africa Anti-Inflammatory Drugs by Countries
9.1 Middle East and Africa Anti-Inflammatory Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Anti-Inflammatory Drugs Sales and Market Share by Country (2020-2028)
9.1.2 Middle East and Africa Anti-Inflammatory Drugs Revenue and Market Share by Country (2020-2028)
9.2 Saudi Arabia Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
9.3 Turkey Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
9.4 Egypt Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
9.5 Nigeria Anti-Inflammatory Drugs Sales and Growth Rate (2020-2028)
10 Anti-Inflammatory Drugs Market In Developing Countries
11 South America Anti-Inflammatory Drugs Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Anti-Inflammatory Drugs Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Continued…
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245